About Us
One of the largest Classical hematology programs in the nation, the University of Pittsburgh Division of Classical Hematology has over 10 physician-scientists and research investigators leading efforts in hemophilia, sickle cell disease, and other rare blood disorders. Through longstanding collaborations with Vitalant and the Hemophilia Center of Western Pennsylvania, the Division integrates a large clinical program with robust basic and translational research.
Research
The Division of Classical Hematology is a nationally recognized leader in advancing the understanding, diagnosis, and treatment of hematologic disorders through basic, translational, and clinical research. With strengths in hemophilia, bleeding disorders, and sickle cell disease, faculty are driving innovations from the lab to the clinic.
>> Read more
Education and Training
Through advanced education and hands-on research under expert mentorship, the Division of Classical Hematology trains the next generation of hematology researchers and clinical leaders. Training is supported by weekly case-based conferences, a research seminar series, and diverse clinical rotations in outpatient hematology, coagulation, and transfusion medicine, with faculty actively mentoring medical students, residents, and fellows at every stage. >> Read more
>> Hematology/Oncology Fellowship Program
>> ASH Hematology Fellowship Program
>> Basic and Translational Research Training
Patient Care
Providing advanced, expert care for patients with conditions such as hemophilia, sickle cell disease, and rare blood disorders, the Division of Classical Hematology delivers timely, specialized diagnostic and treatment guidance through a multidisciplinary team of experts.
>> Read more
News and Events
The Strength Behind the Spotlight: Leading the Way in Porphyria Care
National attention is beginning to turn toward porphyria, a group of rare disorders that can be difficult to recognize, diagnose, and treat. At the University of Pittsburgh and UPMC, that spotlight reflects something that has been steadily taking shape for years: a...
A Genetic Clue to Deadly Lung Clots in Sickle Cell Disease
Tomasz Brzoska, PhD, and colleagues uncover how a CD39 polymorphism disrupts platelet regulation and fuels pulmonary thrombosis.
Donate to the
Division of Classical Hematology
Philanthropy lays the foundation for what we do, and your investment can ensure continued growth and discovery for years to come. Our supporters are partners who help us to envision new possibilities and to improve treatment outcomes.